[Clinical Characteristics and Survival Analysis of Single Center Adult Chronic Myeloid Leukemia in Chronic Phase].
Compared with adult CML-CP patients <60 years, patients ≥60 years gain fewer benefits from TKI treatment and increased adverse reactions.
Authors
- Wen-Li Zhao
- Cai-Qin Lin
- Suli Wang (ORCID: https://orcid.org/0000-0002-1043-4051)
- Xia-Xia Jiao
- Lei-Na Song
- Bin Zhu (ORCID: https://orcid.org/0000-0003-0172-5516)
- Zhiyong Ding (ORCID: https://orcid.org/0000-0001-9981-2241)
- Jing Pan (ORCID: https://orcid.org/0000-0002-3748-4294)
- Haochen Shi (ORCID: https://orcid.org/0000-0002-5641-1517)
- Shao-Ying Pan
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.05.012
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article